Lumbar Cistern Drainage and Gentamicin Intrathecal Injection in the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Intracranial Infection After Intracerebral Hemorrhage craniotomy: A Case Report

References

• Fang C, Zhu T, Zhang P, et al. Risk factors of neurosurgical site infection after craniotomy, A systematic review and meta-analysis. Am J Infect Control. 2017;45(11):e123–e134. doi:10.1016/j.ajic.2017.06.009
   Web of Science ®Google Scholar
• Wang LY, Cao XH, Shi LK, et al. Risk factors for intracranial infection after craniotomy, A case-control study. Brain Behav. 2020;10(7):e01658. doi:10.1002/brb3.1658
   Web of Science ®Google Scholar
• Ramos LL, García C, Iribarren J, et al. Colonization and infection by potential Gram-negative multiresistant microorganism in a medical–surgical ICU. Crit Care. 2008;12(Suppl 2):P36. doi:10.1186/cc6257
   Google Scholar
• Wang L, Huang X, Zhou J, et al. Predicting the occurrence of multidrug-resistant organism colonization or infection in ICU patients, development and validation of a novel multivariate prediction model. Antimicrob Resist Infect Control. 2020;9(1):66. doi:10.1186/s13756-020-00726-5
   Web of Science ®Google Scholar
• Lee B, Yan J, Ulhaq A, et al. Vitro activity of rifabutin and rifampin against antibiotic-resistant Acinetobacter baumannii, Escherichia coli, staphylococcus aureus, pseudomonas aeruginosa, and Klebsiella pneumoniae. mSphere. 2021;6(6):e0092021. doi:10.1128/msphere.00920-21
   Web of Science ®Google Scholar
• Wang J, Yang Y, Lv W, et al. Gentamycin irrigation significantly reduces 28-day surgical site infection after emergency neurosurgery. Br J Neurosurg. 2021;1–5. doi:10.1080/02688697.2021.1902472
   Web of Science ®Google Scholar
• Castro I, Ruiz J, Tasias M, et al. Central nervous system infections in immunocompromised patients. Rev Esp Quimioter. 2018;31(Suppl1):56–61. doi:10.1007/s11910-021-01119-w
   Web of Science ®Google Scholar
• Ernst CM, Braxton JR, Rodriguez-Osorio CA, et al. Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae. Nat Med. 2020;26(5):705–711. doi:10.1038/s41591-020-0825-4
   PubMed Web of Science ®Google Scholar
• Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi:10.1186/s12941-017-0191-3
   PubMed Web of Science ®Google Scholar
• Tian Y, Zhang Q, Wen L, Chen J. Combined effect of polymyxin B and tigecycline to overcome heteroresistance in carbapenem-resistant Klebsiella pneumoniae. Microbiol Spectr. 2021;9(2):e0015221. doi:10.1128/Spectrum.00152-21
   PubMed Web of Science ®Google Scholar
• Liang Q, Huang M, Xu Z. Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Braz J Infect Dis. 2019;23(1):60–65. doi:10.1016/j.bjid.2018.12.004
   PubMed Web of Science ®Google Scholar
• Jin X, Chen Q, Hen F, et al. Resistance evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11 during treatment with tigecycline and polymyxin. Emerg Microbes Infect. 2021;10(1):1129–1136. doi:10.1080/22221751.2021.1937327
   PubMed Web of Science ®Google Scholar
• Kinaci A, Algra A, Heuts S, et al. Effectiveness of dural sealants in prevention of cerebrospinal fluid leakage after craniotomy, a systematic review. World Neurosurg. 2018;118:368–376.e1. doi:10.1016/j.wneu.2018.06.196
   PubMed Web of Science ®Google Scholar
• Ter Horst L, Brouwer MC, van der Ende A, van de Beek D. Community-acquired bacterial meningitis in adults with cerebrospinal fluid leakage. Clin Infect Dis. 2020;70(11):2256–2261. doi:10.1093/cid/ciz649
   PubMed Web of Science ®Google Scholar
• Kinaci A, Van Doormaal TPC. Dural sealants for the management of cerebrospinal fluid leakage after intradural surgery, current status and future perspectives. Expert Rev Med Devices. 2019;16(7):549–553. doi:10.1080/17434440.2019.1626232
   PubMed Web of Science ®Google Scholar
• Hou SY, Wu D, Feng XH. Polymyxin monotherapy versus polymyxin-based combination therapy against carbapenem-resistant Klebsiella pneumoniae, A systematic review and meta-analysis. J Glob Antimicrob Resist. 2020;23:197–202. doi:10.1016/j.jgar.2020.08.024
   Web of Science ®Google Scholar
• Wang J, Liu H, Zheng K, et al. Clinical effect of intrathecal injection of medicine combined with continuous lumbar cistern drainage on intracranial infection after intracranial tumor surgery. Pak J Pharm Sci. 2021;34(1):65–67.
   Web of Science ®Google Scholar
• Qin X, Wu S, Hao M, et al. The colonization of carbapenem-resistant Klebsiella pneumoniae, epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis. 2020;221(Suppl 2):S206–S214. doi:10.1093/infdis/jiz622
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang J, Zhou W, et al. Risk factors and prognosis of carbapenem-resistant Klebsiella pneumoniae infections in respiratory intensive care unit, A retrospective study. Infect Drug Resist. 2021;14:3297–3305. doi:10.2147/IDR.S317233
   Web of Science ®Google Scholar
• Liao W, Liu Y, Zhang W. Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China, A review over the last 10 years. J Glob Antimicrob Resist. 2020;23:174–180. doi:10.1016/j.jgar.2020.09.004
   Web of Science ®Google Scholar
• Yang Y, Yang Y, Chen G, et al. Molecular characterization of carbapenem-resistant and virulent plasmids in Klebsiella pneumoniae from patients with bloodstream infections in China. Emerg Microbes Infect. 2021;10(1):700–709. doi:10.1080/22221751.2021.1906163
   PubMed Web of Science ®Google Scholar
• Magi G, Tontarelli F, Caucci S, et al. High prevalence of carbapenem-resistant Klebsiella pneumoniae ST307 recovered from fecal samples in an Italian hospital. Future Microbiol. 2021;16:703–711. doi:10.2217/fmb-2020-0246
   Web of Science ®Google Scholar
• Li Z, An Y, Li L, Yi H. Intrathecal injection of tigecycline and polymyxin B in the treatment of extensively drug-resistant intracranial Acinetobacter baumannii infection, A case report and review of the literature. Infect Drug Resist. 2022;15:1411–1423. doi:10.2147/IDR.S354460
   Web of Science ®Google Scholar
• Zavascki AP, Klee BO, Bulitta JB. Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill, the pitfalls of aminoglycoside susceptibility. Expert Rev Anti Infect Ther. 2017;15(6):519–526. doi:10.1080/14787210.2017.1316193
   PubMed Web of Science ®Google Scholar
• Chen X, Yin L, Peng L, et al. Synergistic effect and mechanism of plumbagin with gentamicin against carbapenem-resistant Klebsiella pneumoniae. Infect Drug Resist. 2020;13:2751–2759. doi:10.2147/IDR.S265753
   PubMed Web of Science ®Google Scholar
• Gonzalez-Padilla M, Torre-Cisneros J, Rivera-Espinar F, et al. Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae. J Antimicrob Chemother. 2015;70(3):905–913. doi:10.1093/jac/dku432
   PubMed Web of Science ®Google Scholar
• Benenson S, Navon-Venezia S, Carmeli Y, et al. Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin. Int J Infect Dis. 2009;13(5):e295–8. doi:10.1016/j.ijid.2009.01.006
   PubMed Web of Science ®Google Scholar